Active Implantable Medical Devices Market, By Product (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders, Neurostimulators, Implantable Hearing Devices

Active Implantable Medical Devices Market, By Product (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Ventricular Assist Devices, Implantable Heart Monitors/Insertable Loop Recorders, Neurostimulators, Implantable Hearing Devices, Others), By End Users (Hospitals, Ambulatory Surgery Center, Specialty Clinics, Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

Global active implantable medical devices market growth is driven by rising aging population and increasing prevalence of chronic diseases worldwide. Active implantable medical devices are battery-powered medical devices that are implanted inside the human body to treat various medical conditions. Some key active implantable medical devices include implantable cardioverter defibrillators (ICDs), neurostimulators, and implantable drug pumps. ICDs are extensively used to treat life-threatening cardiac conditions like tachycardia and ventricular fibrillation. Neurostimulators help in managing chronic pain as well as neurological disorders such as epilepsy and Parkinson's disease. Implantable drug pumps assist in effective localized drug delivery for conditions like cancer and arthritis. Ongoing medical advancement and growing focus on development of miniaturized and technologically advanced implantable devices can drive the active implantable medical devices market growth during the forecast period.

Market Dynamics:

Rising geriatric population base that is highly susceptible to chronic diseases, increasing demand for minimally invasive procedures, growing prevalence of cardiac disorders and neurological conditions can drive the global active implantable medical devices market growth. According to the United Nations, the population aged 60 years and above is projected to reach 2.1 billion globally by 2050 from 1 billion currently. Growing preference for implantable devices over conventional drug therapy and medical devices due to advantages such as long-term effectiveness and easy remote monitoring can boost adoption of active implantable medical devices. However, limited reimbursement coverage for high-cost implantable devices especially in developing nations, frequent product recalls owing to safety issues, and stringent regulatory approvals can hamper the market growth during the forecast period. Ongoing technological innovation in the field of robotics, bioprinting, 3D printing and development of miniature battery powered devices for long term implantation can offer growth opportunities for active implantable medical devices market players.

Key features of the study:

• This report provides in-depth analysis of the global active implantable medical devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global active implantable medical devices market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic, Cochlear Ltd, Abbott, LivaNova PLC, Boston Scientific Corporation, Myomo, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global active implantable medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global active implantable medical devices market

Detailed Segmentation-

• By Product
• Implantable Cardioverter Defibrillators
• Implantable Cardiac Pacemakers
• Ventricular Assist Devices
• Implantable Heart Monitors/Insertable Loop Recorders
• Neurostimulators
• Implantable Hearing Devices
• Others
• By End Users
• Hospitals
• Ambulatory Surgery Center
• Specialty Clinics
• Others
• By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East
• Africa
• Company Profiles:
• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• LivaNova PLC
• Biotronik SE & Co. KG
• Cochlear Ltd.
• William Demant Holding A/S
• Sonova Holding AG
• MED-EL
• Nurotron Biotechnology Co. Ltd.
• Zimmer Biomet Holdings, Inc.
• Nevro Corp.
• Second Sight Medical Products, Inc.
• Nuvectra Corporation
• Aleva Neurotherapeutics SA
• Pixium Vision
• Retina Implant AG
• Corindus Vascular Robotics, Inc.